Dynamic Technology Lab’s ProQR Therapeutics PRQR Stock Holding History

Dynamic Technology Lab’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,103	Closed	-$223K	–	1268
2018 Q4	$223K	Buy	+14,103	New	+$259K	0.04%	776

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Dynamic Technology Lab's PRQR Position: Q1 2019 in Review

Dynamic Technology Lab sold out of ProQR Therapeutics (PRQR) in Q1 2019, closing a stake of 14,103 shares — an estimated $223K sold.

Dynamic Technology Lab first reported a position in PRQR in Q4 2018 and held it in 1 quarter. The position peaked at $223K in Q4 2018. 56 funds tracked by Wall St. Rank hold PRQR as of Q1 2019.

Dynamic Technology Lab reported no remaining ProQR Therapeutics position as of Q1 2019 after selling out during the quarter.
Dynamic Technology Lab sold 14,103 ProQR Therapeutics shares in Q1 2019, an estimated $223K.
Dynamic Technology Lab first reported a position in ProQR Therapeutics in Q4 2018 and held it in 1 quarter.
Dynamic Technology Lab's ProQR Therapeutics position peaked at $223K in Q4 2018.
56 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2019.

Based on Dynamic Technology Lab's 13F filing for Q1 2019, filed 13 May 2019.